United States — Maine Act or statute

United States — Maine legislation

Maine Revised Statutes, Title 22, § 8735: Compliance, 2019

Covered manufacturers, wholesale drug distributors, and pharmacy benefits managers must certify the accuracy of notifications or reports, may be audited by the organization, and may have to pay audit costs and develop a…

auditscertificationscivil penaltiescompliancecorrective action plans

Professional statute overview

Enactment structure, operative effect and source provenance

Official source

01

Purpose and legislative effect

“Covered manufacturers, wholesale drug distributors, and pharmacy benefits managers must certify the accuracy of notifications or reports, may be audited by the organization, and may have to pay audit costs and develop a corrective action plan. A civil violation can result in a $30,000 daily fine.”

Use this record to locate individual provisions, understand the instrument’s recorded structure, and move from a research summary to the exact source text.

02

How the instrument operates

  1. 01

    Start with the recorded version

    Enacted 2019 · Source version 1 Oct 2025. The date shown identifies this source expression and should not be treated as proof that no later change exists.

  2. 02

    Locate the controlling provision

    Use the provision map, part headings and full-text filter to move from the broad subject to the exact legal language.

  3. 03

    Read conditions and exceptions together

    Keep subsections, definitions, provisos and cross-references in context before drawing a legal conclusion.

  4. 04

    Verify currency and official wording

    Confirm later legislation, commencement notices and corrections with the official publisher before advice, filing or reliance.

03

Research entry points

Selected provisions across the instrument. Open any row to continue with the exact stored text.

Compliance

Covered manufacturers, wholesale drug distributors, and pharmacy benefits managers must certify the accuracy of notifications or reports, may be audited by the organization, and may have to pay audit costs and develop a corrective action plan.…

Section 8735

04

Source and current-law status

Source record view

Source record from legislature.maine.gov · Enacted 2019 · Source version 1 Oct 2025

Verify current force

The source record does not state a definitive current-law status. Check the official publisher and later amendments before relying on this text.

Source-indexed provision map

Sections and provisions

Search by section, heading, part or exact legal wording. Every result remains linked to the stored source record.

Showing 1 of 1 provisions

Offence
§ 8735ComplianceOffence

Covered manufacturers, wholesale drug distributors, and pharmacy benefits managers must certify the accuracy of notifications or reports, may be audited by the organization, and may have to pay audit costs and develop a corrective action plan. A civil violation can result in a $30,000 daily fine.

1. Certification of accuracy. A manufacturer, wholesale drug distributor or pharmacy benefits manager that submits a notification or report to the organization pursuant to this subchapter shall submit with the notification or report a signed written certification of the notification's or report's accuracy. [PL 2019, c. 470, §8 (NEW).] 2. Civil penalty. A manufacturer, wholesale drug distributor or pharmacy benefits manager that violates this subchapter commits a civil violation for which a fine of $30,000 may be adjudged for each day of the violation. [PL 2019, c. 470, §8 (NEW).] 3. Audit. The organization may audit the data submitted by a manufacturer, wholesale drug distributor or pharmacy benefits manager pursuant to this subchapter. The manufacturer, wholesale drug distributor or pharmacy benefits manager shall pay for the costs of the audit. [PL 2019, c. 470, §8 (NEW).] 4. Corrective action plan. The organization may require a manufacturer, wholesale drug distributor or pharmacy benefits manager subject to this subchapter to develop a corrective action plan to correct any deficiencies the organization finds with the manufacturer's, wholesale drug distributor's or pharmacy benefits manager's compliance with this subchapter. [PL 2019, c. 470, §8 (NEW).]
Section 8735Verify source

Legislative relationships

0 referenced instruments

Names are derived from the stored provision headings and citation-enrichment layer. Treat this as a research index and verify each relationship against the source text.

No structured legislative relationships were detected

The statute remains fully searchable by provision. Consult the source text for amendments and cross-references that have not yet been indexed.

Recorded versions and source checkpoint

1 version available in this collection

Current-law checkpoint
  • 1 Oct 2025 · currentEnglish

Source-linked research

Ask AI about this statute

The overview, provisions, and source records above are public. Continue in a separate conversation with this statute’s jurisdiction and source version attached.

No legal research model is currently available.

Sign in

About this LexChat collection

Statute information is organised from identified legislative sources for professional research. Corrections can be reported to hello@esheria.ai.